Cardiac function and obesity

Por Vasan, R S
Publicado em 2003

Association between SNP heterozygosity and quantitative traits in the Framingham Heart Study

Por Govindaraju, D. R., Larson, M. G., Yin, X., Benjamin, E. J., Rao, M. B., Vasan, R. S.
Publicado em 2009

Risk factors for acute ischaemic stroke in young adults in South India

Por Lipska, K, Sylaja, P N, Sarma, P S, Thankappan, K R, Kutty, V R, Vasan, R S, Radhakrishnan, K
Publicado em 2007

Cardiac manifestations of subarachnoid hemorrhage

Por Ahmadian, A, Mizzi, A, Banasiak, M, Downes, K, Camporesi, E M, Thompson Sullebarger, J, Vasan, R, Mangar, D, van Loveren, H R, Agazzi, S
Publicado em 2013

Clinical and echocardiographic correlates of plasma osteopontin in the community: the Framingham Heart Study

Por Ärnlöv, J, Evans, J C, Benjamin, E J, Larson, M G, Levy, D, Sutherland, P, Siwik, D A, Wang, T J, Colucci, W S, Vasan, R S
Publicado em 2006

Circulating Testosterone and SHBG Concentrations Are Heritable in Women: The Framingham Heart Study

Por Coviello, A. D., Zhuang, W. V., Lunetta, K. L., Bhasin, S., Ulloor, J., Zhang, A., Karasik, D., Kiel, D. P., Vasan, R. S., Murabito, J. M.
Publicado em 2011

Red blood cell omega-3 fatty acid levels and markers of accelerated brain aging

Por Tan, Z.S., Harris, W.S., Beiser, A.S., Au, R., Himali, J.J., Debette, S., Pikula, A., DeCarli, C., Wolf, P.A., Vasan, R.S., Robins, S.J., Seshadri, S.
Publicado em 2012

Plasminogen Activator Inhibitor and the Risk of Cardiovascular Disease: The Framingham Heart Study

Por Tofler, G.H., Massaro, J., O'Donnell, C.J., Wilson, P.W.F., Vasan, R.S., Sutherland, P.A., Meigs, J.B., Levy, D., D'Agostino, R.B.
Publicado no Thromb Res (2016)

Inflammatory biomarkers are associated with total brain volume: The Framingham Heart Study

Por Jefferson, A. L., Massaro, J. M., Wolf, P. A., Seshadri, S., Au, R., Vasan, R. S., Larson, M. G., Meigs, J. B., Keaney, J. F., Lipinska, I., Kathiresan, S., Benjamin, E. J., DeCarli, C.
Publicado em 2007